Comorbidity of hypertension and diabetes: The Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET)

American Journal of Cardiology

Volumn 82, Issue 9 SUPPL. 1, 1998, Pages 15-19

  Sowers, James R ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL;

ANGINA PECTORIS; CLINICAL TRIAL; COMORBIDITY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC ANGIOPATHY; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE; TREATMENT OUTCOME;

EID: 0032512039     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9149(98)00751-6     Document Type: Article

References (37)

1. Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: an update. Hypertension 1995;26:869-879.
2. Walsh MF, Dominguez LJ, Sowers JR. Metabolic abnormalities in cardiac ischemia. Cardiol Clin 1995;13:529-538.
3. Hargreaves AD, Logan RL, Elton RA, Buchanan KD, Oliver MF, Riemersmaa RA. Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12 year follow-up and development of coronary heart disease in Edinburgh men. Atherosclerosis 1992;94:61-69.
4. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program working group report on hypertension in diabetes. Hypertension 1994;23:145-158.
5. Salomaa V, Riley W, Kaark JD, Nardo C, Folsom AR. Non-insulin dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial wall stiffness index, the ARIC study. Circulation 1995;91:1432-1443.
6. Stein B, Weintraub WS, Gebhart S. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979-989.
7. Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 1998;158:617-621.
8. Sowers JR. Obesity and cardiovascular disease. Clin Chem 1998;44:1821-1825.
9. John L, Sunder Rao PSS, Kanagasabapathy AS. Rate of progression of albuminuria in type 2 diabetes. Diabetes Care 1994;17:888-890.
10. Schmitz A, Vaeth M, Mogensen CE. Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM. Diabetologia 1994;37:1251-1258.
11. Bakris GL, Weir MR, Sowers JR. Therapeutic challenges in the obese diabetic patient with hypertension. Am J Med 1996;101(suppl):33S-46S.
12. Mitchell TH, Nolan B, Henry M, Cronin C, Baker H, Greely G. Microalbuminuria in patients with non-insulin-dependent diabetes mellitus relates to nocturnal systolic blood pressure. Am J Med 1997;102:531-535.
13. Sowers JR, Sowers PS, Peuler JD. Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis. J Lab Clin Med 1994;123:647-652.
14. Tomiyama H, Doba N, Kushiro T, Yamashita M, Kanmatsuse K, Kajiwara N, Yoshida H, Hinohara S. The relationship of hyperinsulinemic state to left ventricular hypertrophy, micro albuminuria, and physical fitness in borderline and mild hypertension. Am J Hypertens 1997;10:587-591.
15. Mangrum A, Bakris GL. Predictors of renal and cardiovascular mortality in patients with NEDDM: a brief review of microalbuminuria and insulin resistance. Am J Hypertens 1997;11:352-357.
16. Schrier RW. Antihypertensive treatment in type II diabetes. Hosp Pract 1998;11:13-14.
17. Sowers JR, Farrow SL. Treatment of elderly hypertensive patients with diabetes, renal disease and coronary heart disease. Am J Cardiol 1996;6:57-60.
18. Sowers JR, Lester M. Diabetes and cardiovascular disease. Diabetes Care 1998;submitted.
19. 1 and fasting serum glucose in young, diabetic women. Diabetes Care 1980;3:655-658.
20. Ceriello A, Quatraro A, Dello Russo P. Protein C deficiency in insulin dependent diabetes: a hyperglycemia-related phenomenon. Thromb Haemost 1990;64:104-107.
21. Stein JH, Rosenson RS. Lipoprotein Lp(a) excess and coronary heart disease. Arch Intern Med 1997;157:1170-1176.
22. Sowers JR. Impact of lipid and ACE inhibitor therapy on cardiovascular disease and metabolic abnormalities in the diabetic and hypertensive patient. J Hum Hypertens 1997;11:9-16.
23. Afonso LC, Edelson GL, Sowers JR. Metabolic abnormalities in hypertension. Curr Opin Nephrol Hypertens 1997;6:219-223.
24. Nadler JL, Malayan S, Luong H, Shaw S, Natarajan RD, Rude RK. Intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus. Diabetes Care 1992;15:835-841.
25. Standley PR, Ali S, Sowers JR. Increased platelet cytosolic calcium responses to low density lipoprotein in type II diabetes with and without hypertension. Am J Hypertens 1993;6:938-943.
26. Levy J, Gavin JR III, Sowers JR. Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med 1994;96:260-270.
27. Fukuda K, Ozaki Y, Satoh K, Kume S, Tawata M, Onaya T, Sakurada K, Seto M, Sasaki Y. Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation. Diabetes 1997;46:488-493.
28. Tooke JE. Microvascular function in human diabetes. Diabetes 1995;44:721-726.
29. Paston L, Taylor PD. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Circ Res 1995;88:245-255.
30. Tribe RM, Poston L. Oxidative stress and lipids in diabetes: a role in endothelial vasodilator function? Vasc Med 1996;1:195-206.
31. McMillen DE. Development of vascular complications in diabetes. Vasc Med 1997;2:132-142.
32. Yan SD, Schmidt AM, Anderson J. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 1994;269:9989-9997.
33. Lash JP, Bakris GL. Effects of ACE inhibitors and calcium antagonists alone or combined on progression of diabetic nephropathy. Nephrol Dialys Transpl 1995;10(suppl 9):56-62.
34. Epstein M, Bakris GL. Newer approaches to antihypertensive therapy: use of fixed dose combination therapy. Arch Intern Med 1996;156:1969-1978.
35. Tatti P, Pahor M, Byington RP, DiMauro P, Guarisco R, Strollo G, Strollo F. Outcome results of the Fosinopril versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 1998;21:597-603.
36. Califf RM, Granger CB. Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET): more ammunition against surrogate end points. Diabetes Care 1998;21:655-657.
37. Fleming TR, DeMets DL. Surrogate end points in clinical trials: definition and operational criteria. Ann Intern Med 1996;125:605-613.